"We can help answer the fundamental question that every colorectal cancer patient asks after their surgery: 'Am I cured or has my cancer spread?'"

— John Schafer, president/CEO of molecular diagnostics firm DiagnoCure, discussing the company's newly CLIA-certified Previstage test, "New DiagnoCure test focuses on colorectal cancer staging," p. 1, 6.